Clinical trial
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)
NCT00093951
Study timeline
Study start (unknown)2004-04-01Date precision: month
Registry last updated2009-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
SGS742DRUG
Sponsors & collaborators
Saegis Pharmaceuticalslead sponsor
Mapped research locations
MiamiFlorida, United States2San AntonioTexas, United States2ClevelandOhio, United States2San DiegoCalifornia, United States2TampaFlorida, United States2RaleighNorth Carolina, United States2DecaturGeorgia, United States2New YorkNew York, United States1San FranciscoCalifornia, United States1PhoenixArizona, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00093951 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.